Literature DB >> 29470590

Correction to: Chronomedicine and type 2 diabetes: shining some light on melatonin.

Andrew C Forrestel1, Susanne U Miedlich1, Michael Yurcheshen2, Steven D Wittlin1, Michael T Sellix3.   

Abstract

The authors have been made aware that the following sentence is incorrect: 'Like IIK7, both ramelteon and tasimelteon have a greater affinity for the MT2 receptor [162].'

Entities:  

Year:  2018        PMID： 29470590     DOI： 10.1007/s00125-018-4577-3

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


  1 in total

Review 1.  Comparative Review of Approved Melatonin Agonists for the Treatment of Circadian Rhythm Sleep-Wake Disorders.

Authors:  Wilbur P Trey Williams; Dewey E McLin; Marlene A Dressman; David N Neubauer
Journal:  Pharmacotherapy       Date:  2016-09-01       Impact factor: 4.705
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.